Bladder augmentation can be problematic with renal failure and transplantation.
Ten consecutive patients with failure of urinary bladder augmentation (UBA) performed either prior to or after reaching end-stage renal disease (ESRD) were studied. Seven patients developed increased hydroureteronephrosis, infectious complications, and advanced to ESRD after UBA. The mean time to development of ESRD in patients who had UBA performed with moderate chronic renal failure (CRF) was 1.8 years. The UBAs in all seven patients were taken down prior to transplantation. Subsequently, five of these UBA-takedown patients have received kidney grafts and all have stable, good renal function. Three patients had their UBA performed after they reached ESRD, in preparation for renal transplantation. All three of these patients experienced recurrent urosepsis following transplantation, resulting in death in one patient and loss of graft in another. The third patient will undergo takedown of the UBA. This study suggests that UBA may possibly not be the best option for patients with moderate CRF and those awaiting transplantation.
Alfrey
E J
EJ
Department of Surgery, Stanford University, California 94305, USA.
Salvatierra
O
O
Tanney
D C
DC
Mak
R
R
Scandling
J D
JD
Dafoe
D C
DC
Hammer
G B
GB
Orlandi
P D
PD
Page
L
L
Conley
S B
SB
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003106:Colon / Q000637:transplantation; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D012307:Risk Factors; D014182:Transplantation, Autologous; D017211:Treatment Failure; D016896:Treatment Outcome; D001743:Urinary Bladder / Q000601:surgery*